Singapore markets close in 4 hours 58 minutes
Straits Times Index
3,298.92 +6.23 (+0.19%) Nikkei
38,262.58 -11.47 (-0.03%) Hang Seng
18,118.35 +355.32 (+2.00%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,405.90 -2,763.10 (-4.59%) CMC Crypto 200
1,260.29 -78.78 (-5.88%)
Nautilus Biotechnology, Inc. (NAUT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.5400 |
| Open | 2.5900 |
| Bid | 2.5700 x 200 |
| Ask | 3.3200 x 200 |
| Day's range | 2.5300 - 2.9000 |
| 52-week range | 2.1600 - 4.6500 |
| Volume | |
| Avg. volume | 81,139 |
| Market cap | 348.237M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5400 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.25 |
- GuruFocus.com
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
Explore key financial outcomes and strategic insights from Nautilus Biotechnology's first quarter of 2024, emphasizing growth in expenses and future expectations.
GlobeNewswireNautilus Biotechnology Reports First Quarter 2024 Financial Results
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2024. “We continued to make solid progress against our core development goals in Q1,” said Sujal Patel, CEO of Nautilus. “We remain incredibly focused on increasing the scale, stability, and reproducibility of our consumables, assay, instrument, and software
- GuruFocus.com
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected
Details on Financial Performance and Strategic Progress Amidst Development Phase
© 2024 Yahoo. All rights reserved.